Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of ALC.AX is 0.11 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell